Use of weekly GLP-1 agonists as anti-obesity medications: challenges about their effective and safe use in clinical practice and their potential therapeutic applications beyond weight loss

  • 60

    Total views and downloads

About this Research Topic

Submission deadlines

  1. Manuscript Summary Submission Deadline 6 October 2025 | Manuscript Submission Deadline 24 January 2026

  2. This Research Topic is still accepting articles.

Background

Obesity, a chronic, multifactorial, relapsing disease, is associated with an increased risk for multiple medical conditions and is closely linked to excess mortality. The worldwide prevalence of obesity has more than tripled since 1975, with 3 billion people living nowadays with eirher overweight or obesity. Therefore, obesity, a global epidemic, has emerged as one of the most important public health problems facing the world today with a significant impact on healthcare systems and society in general.

To date, lifestyle interventions, encompassing dietary changes and regular physical activity, have been the cornerstone of treatment for obesity, but they have limited long-term efficacy and durability of weight loss for the vast majority of people. Bariatric surgery, albeit highly effective, has remained profoundly underutilised because of several factors. Until recently, the history of pharmacotherapy for weight loss has been marked by withdrawal of numerous medications for safety reasons in combination with limited efficacy, limiting its use to selected cases.

Since 2021, the advent of semaglutide, combing unprecedented efficacy for weight loss with good safety profile, has dramatically changed the landscape of obesity management. It has generated widespread publicity and huge demand, leading to global shortage of supply. In recent years, there has been an exponential rise in prescription of two weekly injectable anti-obesity medications (AOMs), semaglutide and tirzepatide, which produce a greater than 10% placebo-subtracted weight loss in most people. However, several questions remain unanswered about the optimal use of these medications in clinical practice, including uncertainties about predictors of response, optimal duration of treatment and issues about discontinuation, personalizing care, and possible long-term or rare side effects.

In addition, emerging evidence suggests that they can improve clinical outcomes and have direct benefit on weight-related comorbidities, including cardiovascular disease, heart failure, metabolic dysfunction-associated liver disease and obstructive sleep apnea. Numerus studies are also currently their potential application on other medical conditions, such as neurodegenerative diseases and addictions. The impact of these promising agents on the progression and clinical outcomes in a wide variety of conditions remains to be determined.

This research topic aims to explore various aspects of the effectiveness and safety of weekly, injectable AOMs, namely semaglutide and tirzepatide, in day-to-day clinical practice.

This entails numerous questions which have arisen regarding their optimal use, including great heterogeneity of response and factors underlying, duration of use, timing / mode / sequalae of drug discontinuation, different titration/dosing regimens, personalizing use, real-world data, outcomes in subpopulations with specific obesity phenotypes, and long-term safety profile and potential, unknown yet, adverse events.

The other key objectives are to gain further insights
(i) in the impact of these agents on clinical outcomes in patients with obesity and weight-related comorbidities
(ii) in the potential future therapeutic applicability to other medical conditions.

The remit of this research topic would be limited to semaglutide and tirzepatide, without extending neither to other, currently available AOMs nor to novel AOMs in the research pipeline.

We’d welcome articles in the following, but not limited to, subtopics:

- Efficacy for weight loss, including predictors, durability, titration/dosing regimens
- Duration of use and issues related to discontinuation
- Safety profile and adverse events
- Real-world data on the effectiveness and safety of GLP-1 agonists for weight loss
- Challenges and guidance about real-world use of GLP-1 agonists
- Evidence/perspective on personalizing use of GLP-1 agonists for weight loss
- Lifestyle modifications in combination with pharmacotherapy
- Use of GLP-1 agonists as AOMs in specific subpopulations
- Effect of GLP-1 agonists on the clinical outcomes in weight-related comorbidities, ranging from cardiovascular disease and obstructive sleep apnea to osteoarthritis and liver disease
- Potential therapeutic application of GLP-1 agonists to various medical conditions, such as neurological diseases and addictions

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Case Report
  • Clinical Trial
  • Editorial
  • Hypothesis and Theory
  • Methods
  • Mini Review
  • Opinion
  • Original Research
  • Perspective

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: GLP-1 agonists, semaglutide, tirzepatide, anti-obesity medications, obesity, weight loss, pharmacotherapy for obesity, obesity management

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 60Topic views
View impact